Optimizing Tissue Oxygenation in Reduction Mammoplasty: The Role of Continuous Diffusion of Oxygen: A Feasibility Pilot Randomized Controlled Trial

Autor: Zulbaran-Rojas, Alejandro, Bara, Rasha O., Lee, Myeounggon, Flores-Camargo, Areli, Mishra, Ramkinker, Winocour, Sebastian, Thompson, Alastair, Najafi, Bijan

Publikováno v: In Journal of Surgical Research December 2023 292:113-122

Electrical stimulation to regain lower extremity muscle perfusion and endurance in patients with post‐acute sequelae of SARS CoV‐2: A randomized controlled trial.

Autor: Zulbaran‐Rojas, Alejandro, Lee, Myeounggon, Bara, Rasha O., Flores‐Camargo, Areli, Spitz, Gil, Finco, M. G., Bagheri, Amir Behzad, Modi, Dipaben, Shaib, Fidaa, Najafi, Bijan

Publikováno v: Physiological Reports; Mar2023, Vol. 11 Issue 5, p1-15, 15p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Transcutaneous electrical nerve stimulation for fibromyalgia-like syndrome in patients with Long-COVID: a pilot randomized clinical trial.

Autor: Zulbaran-Rojas A; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Bara RO; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Lee M; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.; Center for Advanced Surgical & Interventional Technology (CASIT), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, 700 Westwood Plaza, Suite 2200, Los Angeles, CA, 90095, USA., Bargas-Ochoa M; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Phan T; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Pacheco M; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Camargo AF; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Kazmi SM; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Rouzi MD; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.; Center for Advanced Surgical & Interventional Technology (CASIT), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, 700 Westwood Plaza, Suite 2200, Los Angeles, CA, 90095, USA., Modi D; Department of Pulmonary Critical Care, Baylor College of Medicine, Houston, TX, USA., Shaib F; Department of Pulmonary Critical Care, Baylor College of Medicine, Houston, TX, USA., Najafi B; Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA. najafi.bijan@gmail.com.; Center for Advanced Surgical & Interventional Technology (CASIT), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, 700 Westwood Plaza, Suite 2200, Los Angeles, CA, 90095, USA. najafi.bijan@gmail.com.

Publikováno v: Scientific reports [Sci Rep] 2024 Nov 08; Vol. 14 (1), pp. 27224. Date of Electronic Publication: 2024 Nov 08.

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.

Autor: Allison Stewart C; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tong P; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cardnell RJ; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sen T; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Li L; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gay CM; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Masrorpour F; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Fan Y; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bara RO; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Feng Y; BioMarin Pharmaceutical, San Rafael, CA 94901, USA., Ru Y; BioMarin Pharmaceutical, San Rafael, CA 94901, USA., Fujimoto J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kundu ST; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Post LE; BioMarin Pharmaceutical, San Rafael, CA 94901, USA., Yu K; BioMarin Pharmaceutical, San Rafael, CA 94901, USA., Shen Y; BioMarin Pharmaceutical, San Rafael, CA 94901, USA., Glisson BS; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Heymach JV; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gibbons DL; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Byers LA; Department of Thoracic Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publikováno v: Oncotarget [Oncotarget] 2017 Apr 25; Vol. 8 (17), pp. 28575-28587.